• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有因子V莱顿突变的小鼠的动脉血栓形成

Arterial thrombosis in mice with factor V Leiden mutation.

作者信息

Sampram Ellis S, Saad Yasser, Ouriel Kenneth

机构信息

Department of Vascular Surgery, The Cleveland Clinic, Cleveland, OH, USA.

出版信息

Vascular. 2008 Jan-Feb;16(1):31-4. doi: 10.2310/6670.2008.00007.

DOI:10.2310/6670.2008.00007
PMID:18258160
Abstract

The factor V Leiden (FVL) mutation has been demonstrated to be associated with the development of venous thrombosis in humans. Whether such a propensity also exists in the arterial circulation remains controversial. In an effort to minimize the variability that clouds the clinical study of arterial thrombosis, we studied FVL-associated arterial thrombosis in an experimental model of homozygous, heterozygous, and wild-type mice. Heterozygous FVL mice were crossbred to C57BL/6J mice over several generations. The genotypes of the resulting three genotype groups (wild type, heterozygous FVL, and homozygous FVL) were blinded to the investigators. Arterial injury was produced with the injection of ferric chloride into an isolated segment of carotid artery. Arterial thrombosis was assessed with an ultrasonic flow probe and the time to occlusion (TTO) was recorded. The carotid artery occluded within 60 minutes of injury in 72 of the animals studied (97.3%). The carotid artery remained patent at 60 minutes in the remaining two animals, both of whom were subsequently found to be genotypically wild type. There was a statistically significant relationship between TTO and genotype (p = .002). TTO was greatest in the wild-type mice (p < .001 vs heterozygous, < .001 vs homozygous) and least in the homozygotes (p < .001 vs heterozygotes). Increased thrombogenicity is present in mice with the FVL mutation and is more prolonged in homozygotes than heterozygotes. These findings provide some corroboration to the clinical studies that suggest an increased risk of arterial events in patients with the FVL mutation.

摘要

已证实因子V莱顿(FVL)突变与人类静脉血栓形成有关。这种倾向在动脉循环中是否也存在仍存在争议。为了尽量减少使动脉血栓形成临床研究结果模糊不清的变异性,我们在纯合子、杂合子和野生型小鼠的实验模型中研究了FVL相关的动脉血栓形成。杂合子FVL小鼠与C57BL/6J小鼠杂交了几代。研究人员对所得三个基因型组(野生型、杂合子FVL和纯合子FVL)的基因型不知情。通过向颈动脉的一个孤立节段注射氯化铁来造成动脉损伤。用超声血流探头评估动脉血栓形成,并记录闭塞时间(TTO)。在研究的72只动物中(97.3%),颈动脉在损伤后60分钟内闭塞。其余两只动物的颈动脉在60分钟时仍保持通畅,后来发现它们的基因型均为野生型。TTO与基因型之间存在统计学上的显著关系(p = 0.002)。野生型小鼠的TTO最长(与杂合子相比p < 0.001,与纯合子相比p < 0.001),纯合子的TTO最短(与杂合子相比p < 0.001)。FVL突变小鼠存在血栓形成增加的情况,且纯合子比杂合子更为持久。这些发现为临床研究提供了一些佐证,这些临床研究表明FVL突变患者发生动脉事件的风险增加。

相似文献

1
Arterial thrombosis in mice with factor V Leiden mutation.具有因子V莱顿突变的小鼠的动脉血栓形成
Vascular. 2008 Jan-Feb;16(1):31-4. doi: 10.2310/6670.2008.00007.
2
Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.凝血因子V莱顿纯合子会导致小鼠血栓形成和动脉粥样硬化加剧。
Circulation. 2005 Apr 12;111(14):1822-5. doi: 10.1161/01.CIR.0000160854.75779.E8. Epub 2005 Apr 4.
3
Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation.
Transplant Proc. 2013 Jun;45(5):1990-3. doi: 10.1016/j.transproceed.2012.10.058.
4
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.在凝血因子V莱顿突变小鼠中静脉血栓形成较动脉血栓形成增加。
Thromb Res. 2007;119(6):747-51. doi: 10.1016/j.thromres.2006.02.014. Epub 2006 Jun 21.
5
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.在因子V莱顿转基因小鼠中评估因子V莱顿突变在感染性腹膜炎中的作用。
Crit Care Med. 2006 Aug;34(8):2201-6. doi: 10.1097/01.CCM.0000228918.30931.E8.
6
[Effect of alpha-galactosidase A deficiency on FV leiden fibrin deposition and thrombosis in mice].[α-半乳糖苷酶A缺乏对小鼠FV莱顿纤维蛋白沉积和血栓形成的影响]
Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):162-5.
7
Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.患有杂合子因子V莱顿突变的缺血性中风患者会出现多发性脑梗死和广泛的动脉粥样硬化血栓形成疾病。
Thromb Haemost. 2009 Jan;101(1):145-50.
8
Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family.遗传性蛋白 C 缺乏与血栓风险:一个意大利大家族的基因型与表型关系。
Eur J Haematol. 2012 Apr;88(4):336-9. doi: 10.1111/j.1600-0609.2011.01742.x. Epub 2012 Jan 10.
9
Factor V Leiden mutation is associated with enhanced arterial thrombotic tendency in lean but not in obese mice.凝血因子V莱顿突变与瘦小鼠而非肥胖小鼠的动脉血栓形成倾向增强有关。
Thromb Haemost. 2007 Oct;98(4):858-63.
10
Clinical manifestations in thrombotic children with factor V Leiden mutation.
Pediatr Hematol Oncol. 1999 May-Jun;16(3):233-7. doi: 10.1080/088800199277281.

引用本文的文献

1
APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.由于因子 V 莱顿导致的 APC 抵抗与基线炎症介质或 10 年内严重肢体缺血患者的生存无关。
J Thromb Thrombolysis. 2013 Oct;36(3):288-92. doi: 10.1007/s11239-012-0845-0.